Prevalence Of Insulin Resistance In Type -2 Diabetes Mellitus Patients

Authors

  • L. Anjana
  • Pravin Selvam
  • R. Shanmugasundaram

DOI:

https://doi.org/10.52783/jns.v14.2829

Keywords:

Insulin resistance, HOMA – IR, fasting plasma insulin, fasting blood glucose

Abstract

Insulin is a peptide hormone produced by the beta cells of pancreas. It  plays a major role  in  the regulation of blood sugar level  . Insulin promotes glycogenesis and inhibits glycogenolysis and lipolysis. This dysregulation of insulin hormone function can lead to insulin resistance. Insulin resistance  is  a condition  in which the cells fail  to respond  to  insulin  resulting in impaired glucose uptake  and  hyperglycemia . Insulin resistance is of great significance nowadays , as it causes obesity , hypertension , dyslipidemia  and  cardiovascular  diseases. The aim of  the study is to estimate the prevalence of  insulin resistance  in  the type 2 diabetes  mellitus patients. And a cross sectional   study  was conducted among them. And   insulin resistance   is calculated by  globally accepted  standard  HOMA –IR  method.  After  8  hours  of  fasting  , type- 2 diabetes  mellitus  patients  were  subjected  to  fasting   plasma  insulin and  fasting  plasma  blood  glucose   tests .

HOMA- IR  is homeostasis model  assessment  for  insulin  resistance HOMA IR-  (Fasting  plasma  insulin x fasting  blood  glucose) /  405 When the insulin  resistance was  calculated  among  the  type - 2   diabetes mellitus  patients by OMA – IR method, it  was  found  to  be  high  (insulin resistance  ->1.9  to  2.9) .Where as  in other  individuals,   insulin resistance  was  found to  be normal  (IR - < 1.4 . From the study , insulin resistance  was found to be 65%  among the diabetics  and 35 %  among  the non- diabetics respectively . If the insulin resistance was detected at an earlier stage among the diabetics, complications like metabolic syndrome can be avoided. Patients can be given treatment accordingly. Thus morbidity and mortality  among  the  diabetics  will become less.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Seong J, Kang JY, Sun JS, Kim KW. Hypothalamic inflammation and obesity: a mechanistic review. Arch Pharm Res. 2019 May;42(5):383-392. [PubMed]

Brown JC, Harhay MO, Harhay MN. The Value of Anthropometric Measures in Nutrition and Metabolism: Comment on Anthropometrically Predicted Visceral Adipose Tissue and Blood-Based Biomarkers: A Cross-Sectional Analysis. NutrMetab Insights. 2019;12:1178638819831712. [PMC free article] [PubMed]

Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diab Vasc Dis Res. 2019 Mar;16(2):118-127. [PubMed]

Deacon CF. Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes. Front Endocrinol (Lausanne). 2019;10:80. [PMC free article] [PubMed]

Thomas DD, Corkey BE, Istfan NW, Apovian CM. Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. J Endocr Soc. 2019 Sep 01;3(9):1727-1747. [PMC free article] [PubMed]

Hossan T, Kundu S, Alam SS, Nagarajan S. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus. EndocrMetab Immune Disord Drug Targets. 2019;19(6):775-786. [PubMed]

Bothou C, Beuschlein F, Spyroglou A. Links between aldosterone excess and metabolic complications: A comprehensive review. Diabetes Metab. 2020 Feb;46(1):1-7. [PubMed]

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9. [PubMed]

Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998 Dec;21(12):2191-2. [PubMed]Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10. [PubMed]

Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism. 2010 Feb;59(2):299-304. [PubMed]

Tobin GS, Cavaghan MK, Hoogwerf BJ, McGill JB. Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy. Int J Clin Pract. 2012 Dec;66(12):1147-57. [PMC free article] [PubMed]

Abdul-Ghani M, DeFronzo RA. Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken. J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1897-e1899. [PMC free article] [PubMed]

Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK, Grønbæk H. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. World J Hepatol. 2019 Feb 27;11(2):138-149. [PMC free article] [PubMed]

Pennings N, Jaber J, Ahiawodzi P. Ten-year weight gain is associated with elevated fasting insulin levels and precedes glucose elevation. Diabetes Metab Res Rev. 2018 May;34(4):e2986. [PubMed]

Church TJ, Haines ST. Treatment Approach to Patients With Severe Insulin Resistance. Clin Diabetes. 2016 Apr;34(2):97-104. [PMC free article] [PubMed]

Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012 Dec;33(6):981-1030. [PMC free article] [PubMed]

Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv Exp Med Biol. 2017;960:1-17. [PubMed]

Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res. 2020;2020:3920196. [PMC free article] [PubMed]

Nellaiappan K, Preeti K, Khatri DK, Singh SB. Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies. Curr Diabetes Rev. 2022;18(1):e030821192146. [PubMed]

Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006 Jun;83(6):1237-47. [PubMed]

McCormick N, O'Connor MJ, Yokose C, Merriman TR, Mount DB, Leong A, Choi HK. Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization. Arthritis Rheumatol. 2021 Nov;73(11):2096-2104. [PMC free article] [PubMed]

Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008 Nov;88(11):1254-64. [PMC free article] [PubMed]

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 07;346(6):393-403. [PMC free article] [PubMed]

Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016 Jan;126(1):12-22. [PMC free article] [PubMed]

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D., Diabetes Prevention Program Research Group. Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes Care. 2019 Sep;42(9):1809-1815. [PMC free article] [PubMed]

Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, Yorifuji T, Katagiri H. New classification and diagnostic criteria for insulin resistance syndrome. Endocr J. 2022 Feb 28;69(2):107-113. [PubMed]

Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003 Feb 24;163(4):427-36. [PMC free article] [PubMed]

Parcha V, Heindl B, Kalra R, Li P, Gower B, Arora G, Arora P. Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANES. J Clin Endocrinol Metab. 2022 Jan 01;107(1):e25-e37. [PMC free article] [PubMed]

Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018 Oct 01;98(4):2133-2223. [PMC free article]

Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998 Aug;83(8):2694-8. [PubMed]

Downloads

Published

2025-03-31

How to Cite

1.
Anjana L, Selvam P, Shanmugasundaram R. Prevalence Of Insulin Resistance In Type -2 Diabetes Mellitus Patients. J Neonatal Surg [Internet]. 2025Mar.31 [cited 2025Sep.13];14(10S):401-6. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/2829

Similar Articles

You may also start an advanced similarity search for this article.